|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 5/08 | (2006.01) |
| A61K 38/25 | (2013.01) | ||
| A61M 5/315 | (2006.01) | ||
| A61M 5/31596 | (2013.01) | ||
| A61K 38/25 | (2006.01) | ||
| A61P 5/08 | (2018.01) |
| (11) | Number of the document | 3773682 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19712611.3 |
| Date of filing the European patent application | 2019-03-28 | |
| (97) | Date of publication of the European application | 2021-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2019/057845 |
| Date | 2019-03-28 |
| (87) | Number | WO 2019/185786 |
| Date | 2019-10-03 |
| (30) | Number | Date | Country code |
| 1852662 | 2018-03-28 | FR |
| (72) |
GONZALEZ GARCIA, Maria Isabel , ES
ROCA TORRELLAS, José Maria , ES
BOURGOIS, Tabatha , ES
LACHAMP, Laurence , ES
LACOMBE, Frederic , ES
|
| (73) |
Edix SA ,
5, boulevard de la Pétrusse, 2320 Luxembourg,
LU
|
| (54) | PRÉSENTATIONS INJECTABLES, SERINGUES ET COMPOSITIONS À LIBÉRATION PROLONGÉE ET/OU CONTROLÉE DE LANRÉOTIDE |
| INJECTABLE PRESENTATIONS, SYRINGES AND COMPOSITIONS WITH SUSTAINED AND/OR CONTROLLED RELEASE OF LANREOTIDE |